The Sildenafil Drug Market Poised to Witness High Growth Owing to Increasing Prevalence of Erectile Dysfunction
Sildenafil Drug Market |
The sildenafil drug market comprises drugs used for the treatment of erectile
dysfunction in men. Sildenafil, sold under the brand name Viagra among others,
is a drug commonly used to treat erectile dysfunction and pulmonary arterial
hypertension. It works by inhibiting phosphodiesterase type 5, increasing blood
flow to the penis during sexual stimulation. The global sildenafil drug market
is estimated to be valued at US$ 2.9 Bn in 2023 and is expected to exhibit a
CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new
report published by Coherent Market Insights.
Market Dynamics:
One of the key drivers propelling the growth of the sildenafil drug market is
the increasing prevalence of erectile dysfunction among men. Erectile
dysfunction is a common type of male sexual dysfunction characterized by the
inability to develop or maintain an erection of the penis during sexual
activity. Changing lifestyles, lack of physical activity, and growing
consumption of tobacco and alcohol is contributing to the rising cases of
erectile dysfunction, thereby fueling the demand for sildenafil drugs.
Additionally, the popularity of generic versions of sildenafil drugs due to
their low cost compared to branded drugs is also driving market growth.
However, availability of alternative treatment options such as penile implants,
counseling, lifestyle changes, and testosterone replacement therapy are factors
expected to hamper the sildenafil drug market growth over the forecast period.
SWOT Analysis
Strength: Sildenafil drug is widely used for treating erectile dysfunction in
men. It is known to be highly effective in resolving such issues within 30-60
minutes of consumption. Being an oral tablet, it offers easy administration to
patients. Generic versions are also available at lower costs.
Weakness: Sildenafil may cause certain side effects like headaches,
indigestion, blurred vision, back pain etc. in some users. There are also
potential risks of hypotension, myocardial infarction on exertion, prolonged
erection etc. It may not be suitable for patients suffering from certain conditions
or those on some other medications.
Opportunity: The market has strong potential for growth in developing nations
due to increasing awareness about lifestyle disorders and availability of
generic drugs. Teleconsultation services are also promoting usage for such
indications. Innovation in delivery forms like film, spray etc. may aid
adherence and attract new consumers.
Threats: Entry of alternative drugs for treating erectile dysfunction and
availability of herbal supplements in some markets pose competition.
Regulations on direct-to-consumer marketing of such products can also limit
promotions. Patent expiries of branded drugs enable availability of more
affordable generics lowering potential revenues.
Key Takeaways
The global Sildenafil
Drug Market Size is expected to witness high growth at a CAGR of 6.8%
during the forecast period of 2023 to 2030. This can be attributed to rising
prevalence of lifestyle disorders like diabetes impacting sexual health,
growing health awareness regarding such issues and availability of generic
alternatives at lower costs enhancing affordability.
Regional analysis: North America currently dominates with the highest market
share owing to well established healthcare infrastructure and high adoption of
advanced medications. However, Asia Pacific region is projected to emerge as
the fastest growing market due to rising health expenditures, increasing
patient pool of erectile dysfunction, growing health awareness and expanding
penetration of generic drug manufacturers in nations like China and India.
Key players: Key players operating in the Sildenafil drug market are Pfizer,
Teva Pharmaceuticals, Aurobindo Pharma, Alembic Pharmaceuticals, Torrent
Pharmaceuticals, Lupin, Dr Reddy's Laboratories, Zydus Cadila, Amneal
Pharmaceuticals, Hetero, Apotex, Mylan, Ajanta Pharma, Sun Pharmaceutical,
Cipla, Novartis, Eli Lily, Sanofi, Bayer, GlaxoSmithKline. Along with product
innovations and promotions, these companies are focused on expanding their
presence across emerging markets to tap the future profitable opportunities.
For more insights, Read- https://www.ukwebwire.com/sildenafil-drug-market-growth-market-size-share-analysis/
Comments
Post a Comment